TG accumulation inhibitory effects of Jinqi formula by AMPK signaling pathway

Journal of Ethnopharmacology

Volumn 143, Issue 1, 2012, Pages 41-48

  Qian, Qian ^a   Liu, Xuefeng ^a   He, Wei ^a   An, Yating ^a   Chen, Qi ^a   Wu, Jianxia ^a   Deng, Yanru ^a   Guo, Liping ^a   Zhang, Yi ^a   Wang, Tao ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

AMPK signaling pathway; Gene expression; Jinqi formula; Lipogenic enzyme; TG accumulation

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CHINESE DRUG; FATTY ACID; FATTY ACID SYNTHASE; GLUCOSE; HORMONE SENSITIVE LIPASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; JINQI; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALI RHADIX; CELL STRAIN 3T3; CONTROLLED STUDY; COPTIS; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; LIVER; LONICERAE JAPONICAE; MEDICINAL PLANT; MOUSE; MUSCLE TISSUE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING;

3T3-L1 CELLS; ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANGIOSPERMS; ANIMALS; ASTRAGALUS PLANT; BLOOD GLUCOSE; BODY WEIGHT; COPTIS; DRUGS, CHINESE HERBAL; FATTY ACIDS; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIVER; LONICERA; MALE; MICE; MICE, INBRED STRAINS; MUSCLE, SKELETAL; PHOSPHORYLATION; PHYTOTHERAPY; SIGNAL TRANSDUCTION; STEROL ESTERASE; TRIGLYCERIDES; UP-REGULATION;

FLOS; MUS;

EID: 84864646034     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.05.052     Document Type: Article

References (31)

1. D.M. Breen, T. Sanli, A. Giacca, and E. Tsiani Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK Biochemical and Biophysical Research Communications 374 2008 117 122
2. H. Cao, M. Ren, L. Guo, H. Shang, J. Zhang, Y. Song, H. Wang, B. Wang, X. Li, J. Hu, X. Wang, D. Wang, J. Chen, S. Li, and L. Chen JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial Trials 11 2010 27 34
3. L. Feng, Y.F. Song, Q.B. Guan, H.J. Liu, B. Ban, H.X. Dong, X.L. Hou, K.O. Lee, L. Gao, and J.J. Zhao Long-term ethanol exposure inhibits glucose transporter 4 expression via an AMPK-dependent pathway in adipocytes Acta Pharmacologicca Sinica 31 2010 329 340
4. J. Gamble, and G.D. Lopaschuk Insulin inhibition of 5′ adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation Metabolism 46 1997 1270 1274
5. C. Han Comparison of anti-hyperglycemic effect of inorganic constituents and organic in traditional Chinese medicine, Jinqi compound recipe Biological Trace Element Research 131 2009 55 61
6. D.G. Hardie, and D. Carling The AMP-activated protein kinase - fuel gauge of the mammalian cell? European Journal of Biochemistry 246 1997 259 273
7. S. Hasani-Ranjbar, N. Nayebi, B. Larijani, and M. Abdollahi A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity World Journal of Gastroenterology 15 2009 3073 3085
8. S.L. Huang, R.T. Yu, J. Gong, Y. Feng, Y.L. Dai, F. Hu, Y.H. Hu, Y.D. Tao, and Y. Leng Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice Diabetologia 55 2012 1469 1481
9. S.N. Jakobsen, D.G. Hardie, N. Morrice, and H.E. Tornqvist 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside Journal of Biological Chemistry 276 2001 46912 46916
10. M. Kohjima, N. Higuchi, M. Kato, K. Kotoh, T. Yoshimoto, T. Fujino, M. Yada, R. Yada, N. Harada, M. Enjoji, R. Takayanagi, and M. Nakamuta SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease International Journal of Molecular Medicine 21 2008 507 511
11. S. Koren, L. Shemesh-Bar, A. Tirosh, R.K. Peleg, S. Berman, R.A. Hamad, S. Vinker, A. Golik, and S. Efrati The effect of sitagliptin versus glibenclamide on arterial stiffness, blood pressure, lipids, and inflammation in Type 2 diabetes mellitus patients Diabetes Technology and Therapeutics 2012 14 10.1089/dia.2011.0296
12. N. Kubota, Y. Terauchi, T. Kubota, H. Kumagai, S. Itoh, H. Satoh, W. Yano, H. Ogata, K. Tokuyama, I. Takamoto, T. Mineyama, M. Ishikawa, M. Moroi, K. Sugi, T. Yamauchi, K. Ueki, K. Tobe, T. Noda, R. Nagai, and T. Kadowaki Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways Journal of Biological Chemistry 281 2006 8748 8755
13. N.K. LeBrasseur, M. Kelly, T.S. Tsao, S.R. Farmer, A.K. Saha, N.B. Ruderman, and E. Tomas Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues American Journal of Physiology-Endocrinology and Metabolism 291 2006 E175 E181
14. Y.S. Lee, W.S. Kim, K.H. Kim, M.J. Yoon, H.J. Cho, Y. Shen, J.M. Ye, C.H. Lee, W.K. Oh, C.T. Kim, C. Hohnen-Behrens, A. Gosby, E.W. Kraegen, D.E. James, and J.B. Kim Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states Diabetes 55 2006 2256 2264
15. K.W. Liang, S.C. Yin, C.T. Ting, S.J. Lin, C.M. Hsueh, C.Y. Chen, and S.L. Hsu Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells European Journal of Pharmacology 590 2008 343 354
16. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method Methods 25 2001 402 408
17. Y.C. Long, Z. Cheng, K.D. Copps, and M.F. White Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways Molecular Cell Biology 31 2011 430 441
18. J. Mantovani, and R. Roy Re-evaluating the general(ized) roles of AMPK in cellular metabolism FEBS Letters 585 2011 967 972
19. M.F. McCarty AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome Medical Hypotheses 64 2005 1211 1215
20. S.H. Park, S.R. Gammon, J.D. Knippers, S.R. Paulsen, D.S. Rubink, and W.W. Winder Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle Journal of Applied Physiology 92 2002 2475 2482
21. S.H. Park, S.R. Paulsen, S.R. Gammon, K.J. Mustard, D.G. Hardie, and W.W. Winder Effects of thyroid state on AMP-activated protein kinase and acetyl-CoA carboxylase expression in muscle Journal of Applied Physiology 93 2002 2081 2088
22. P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J.R. Zierath, and B.K. Pedersen Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 54 2005 2939 2945
23. C.M. Rondinone, L.M. Wang, P. Lonnroth, C. Wesslau, J.H. Pierce, and U. Smith Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus Proceedings of the National Academy of Sciences USA 94 1997 4171 4175
24. N.B. Ruderman, A.K. Saha, and E.W. Kraegen Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity Endocrinology 144 2003 5166 5171
25. G. Schimmack, R.A. Defronzo, and N. Musi AMP-activated protein kinase: Role in metabolism and therapeutic implications Diabetes, Obesity and Metabolism 8 2006 591 602
26. D.M. Thomson, and W.W. Winder AMP-activated protein kinase control of fat metabolism in skeletal muscle Acta Physiologica (Oxford) 196 2009 147 154
27. J.M. Ye, N. Dzamko, M.E. Cleasby, B.D. Hegarty, S.M. Furler, G.J. Cooney, and E.W. Kraegen Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin Diabetologia 47 2004 1306 1313
28. C.O. Yi, B.T. Jeon, H.J. Shin, E.A. Jeong, K.C. Chang, J.E. Lee, D.H. Lee, H.J. Kim, S.S. Kang, G.J. Cho, W.S. Choi, and G.S. Roh Resveratrol activates AMPK and suppresses LPS-induced NF-kappaB-dependent COX-2 activation in RAW 264.7 macrophage cells Anatomy and Cell Biology 44 2011 194 203
29. B.B. Zhang, G. Zhou, and C. Li AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metabolism 9 2009 407 416
30. Y. Zhang, Q. Qian, D.D. Ge, Y.H. Li, X.R. Wang, Q. Chen, X.M. Gao, and T. Wang Identification of Benzophenone C-Glucosides from Mango Tree Leaves and their inhibitory effect on triglyceride accumulation in 3T3-L1 adipocytes Journal of Agricultural and Food Chemistry 59 2011 11526 11533
31. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action Journal of Clinical Investigation 108 2001 1167 1174